Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Very High Definition Cohort: Assessment of New Prognostic Biomarkers of Disability Worsening in a Multicenter Cohort of MS Patients by Imaging, Optical Coherence Tomography and Biology

NCT05622643 is registered in ClinicalTrials.gov with EDMUS Foundation as lead sponsor.

NCT NCT05622643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05622643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Very High Definition Cohort: Assessment of New Prognostic Biomarkers of Disability Worsening in a Multicenter Cohort of MS Patients by Imaging, Optical Coherence Tomography and Biology
Lead sponsor
EDMUS Foundation
Phase
Observational
Overall status
Active, not recruiting
Start date
January 19, 2023
Completion date
December 1, 2027
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis